Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic

Clinical Trial ID NCT00893711

PubWeight™ 1.83‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00893711

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007 2.10
2 Focus on infantile colic. Acta Paediatr 2007 1.27
3 Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 2004 1.21
4 Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol 2005 1.19
5 A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytother Res 2005 1.14
6 A prospective 10-year study on children who had severe infantile colic. Acta Paediatr Suppl 2005 1.07
7 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One 2013 1.06
8 Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr 2006 0.94
9 Ghrelin and motilin concentration in colicky infants. Acta Paediatr 2006 0.80
10 Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis. BMJ Open 2014 0.77
11 Must infants with colic really be hospitalized? Acta Paediatr 2007 0.76
Next 100